contrast, in NIDDM patients daily magnesium administration, restoring a more appropriate present in living cells and its plasma concentration is remarkably constant in healthy intracellular magnesium concentration, contributes to improve insulin-mediated glucose subjects. Plasma and intracellular magnesium concentrations are tightly regulated by several uptake. Similarly, in HP patients magnesium administration may be useful in decreasing factors. Among them, insulin seems to be one of the most important. In fact, in vitro and in vivo arterial blood pressure and improving insulinmediated glucose uptake. The benefits deriving studies have demonstrated that insulin may modulate the shift of magnesium from from daily magnesium supplementation in NIDDM and HP patients are further supported by extracellular to intracellular space. Intracellular magnesium concentration has also been shown to epidemiological studies showing that high daily magnesium intake to be predictive of a lower be effective on modulating insulin action ( mainly oxidative glucose metabolism) , offset calciumincidence of NIDDM and HP.
less than 15% from this value. The distribution of normal values for serum and plasma magnesium are similar in men and women, and almost one-third is bound to plasma proteins. The remaining two-thirds, which are diffusible or ionized, appear to be the biologically active component. 1, 2 In normal persons, to maintain an adequate magnesium balance, daily magnesium intakes should be around 350 mg / day in men and 300 mg / day in women. There is evidence that daily magnesium intake has been progressively decreasing since the beginning of this century and the average intake in western countries is often under the ''recommended dietary allowance'' ( RDA ) reported above.
Small intestine is the main site for magnesium absorption, whereas magnesium excretion is mainly performed through renal pathways. Although no known hormonal factor is specifically involved in the regulation of magnesium metabolism similar to vitamin D for calcium metabolism, many hormones are known to affect magnesium balance and transport. 2 Among them, calcitonin and parathormone have long been thought to play a major role. Noradrenaline and adrenaline appear to have different effects depending upon the tissue considered, since they stimulate magnesium uptake by fat cells while they reduce magnesium uptake by cardiac muscle cells.
FIGURE 1 . Changes in blood glucose, plasma insulin, and

ROLE OF INSULIN AS A REGULATORY plasma and erythrocyte magnesium concentrations in response to
HORMONE FOR MAGNESIUM oral glucose load ( 75 g ) . Results are expressed as mean { SEM
Insulin has been proposed as a regulatory hormone (n Å 10 ) . *P õ .05; * *P õ .01 ( from Paolisso et al, 4 with permission ) .
of the magnesium balance. Lostroh and Krahl were the first to demonstrate that insulin added in vitro promptly promotes a net increase in the accumulation of magnesium and potassium in uterine smooth mus-Barbagallo et al, using nuclear magnetic resonance techniques to measure intracellular free magnesium cle cells. 3 These authors suggested that insulin, after interacting with its own receptor on plasma mem-( Mg i ) and cytosolic free calcium ( Ca i ) , showed that the ionic action of insulin is specific, dose-related, and brane, can affect an ATPase pump increasing magnesium and potassium cellular entry. 3 Several in vivo independent of cellular glucose uptake. 5 A quantity of 1.4 mmol / L of insulin in the incubation medium and in vitro data support a role for insulin on magnesium transport. Paolisso studied the role of insulin in was able to induce an accumulation of intracellular free magnesium, which shifted from a basal value of regulating the redistribution of plasma and erythrocyte Mg levels in healthy, nondiabetic individuals. 177 { 11 to 209 { 19 mmol / L. 5 These data suggest that insulin is an important modulator of intracellular Following ingestion of a glucose load, insulin caused a shift of magnesium from the extracellular to the in-magnesium content; furthermore, there are indications that, as in other energy producing systems, an tracellular space, thus producing a significant decline in plasma magnesium with a contemporary increase ATPase-dependent pump is involved in the mechanism by which insulin regulates the erythrocyte magin erythrocyte magnesium content 4 ( Figure 1 ) . Opposite changes in plasma and erythrocyte magnesium nesium content. 4 The modulatory role of insulin on intracellular magnesium has been also confirmed in levels are also seen during the course of a euglycemic hyperinsulinemic glucose clamp 4 ( Figure 2 ) . In vitro platelets. 6 Interestingly, Hwang et al showed that the insulin effect on intracellular magnesium is totally data have also provided evidence that erythrocytes accumulate magnesium in the presence of insulin ( 710 abolished by a monoclonal antibody directed towards the insulin receptor, thus suggesting that intracellular pmol / L ) and glucose ( 5 mmol / L ) , an effect entirely abolished by ouabain, 4 whereas glucose alone at these magnesium accumulation depends upon activation of the insulin receptor. concentrations ( 5 mmol / L ) had no significant effect.
contraction coupling, and decrease cellular responsiveness to depolarizing stimuli, by stimulating Ca 2/ -dependent K / channels, which serve to offset the potential depolarizing influence of cellular calcium accumulation by activating the membrane Na-K-ATPase pump, which is critical for the maintenance of the resting cellular membrane potential, by competitively inhibiting Ca binding to calmodulin, and by stimulating both plasma membrane and sarcoplasmic reticulum Ca ATPases.
7 -10 Consistent with the above, not only calcium-induced contraction in VSM is sensitive to changes in magnesium concentration, 7 -9 but direct reduction of extracellular magnesium raises smooth muscle Ca 2/ content, whereas conversely, elevations in Mg 2/ concentrations reciprocally lower calcium content in smooth muscle.
11 Moreover, magnesium directly affects uptake, distribution, and content of calcium in vascular smooth muscle cells, 8 and can itself function as a weak calcium channel blocker, modulating calcium-channel activity in heart cells, 12 and causing vasodilatation comparable to pharmacologic calcium channel blockade. 13 Indeed, vascular hyperreactivity and frank hypertension 14 -18 could be induced by depletion of magnesium both in the in vitro environment, or in the organism as a whole. Magnesium ions have been shown to directly alter baseline tension or tone of blood vessels.
14 -16 Reductions of extracellular magnesium produce an increase of the contractile tension, whereas an elevation in magnesium concentrations lowers baseline tension in a variety of mammalian arteries and arterioles. Altura and Altura have over, when a chelating agent ( Ca EDTA ) that selectively removes magnesium is added to the medium, the arterial muscle contracts; when one that selec-MAGNESIUM AND HYPERTENSION tively chelates calcium is added, the arterial muscle relaxes.
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The role of magnesium ions in the physiologic regulation of cardiac and vascular smooth muscle activity In view of such direct and indirect actions of magnesium on cardiac and vascular smooth muscle, it is is well known. Magnesium is a necessary cofactor in all ATP-transfer reactions, and thus regulates the ac-reasonable to suggest that magnesium deficiency might be relevant to disorders of blood pressure hotivity of the rate-limiting enzymes of glycolysis. Additionally, magnesium modulates the activity of many meostasis, such as hypertension. However, until recently, despite the importance of magnesium at the plasma membrane and intracellular ion transport pump mechanisms, which maintain critical intracellu-cellular level, there was little evidence for altered magnesium metabolism in clinical hypertension. Mealar levels of cytosolic free calcium and sodium. The role of calcium in stimulus -contraction coupling and surements of serum magnesium levels are not useful, as no distinct alterations of circulating total magnerelaxation is itself dependent on intracellular steadystate activities of magnesium. In particular, it is now sium levels have been identified in essential hypertension. However, several abnormalities of magnesium clear that magnesium ion, although not directly involved in the biochemical process of contraction, metabolism have long been recognized in hypertensive subjects. Epidemiological studies have suggested modulates vascular smooth muscle tone and contractility by affecting calcium ion concentrations and its that an inverse relation exists between magnesium intake and hypertension, lower dietary magnesium inavailability at critical sites. Magnesium ions actively promote relaxation, offset calcium-related excitation-take being associated with higher blood pressure. 19, 20 / 2e0f$$2136 02-03-97 16:57:25 eajha EL: AJH
In an aging population, a gradual fall in serum mag-magnesium averaged 0.79 { 0.01 mmol / L in 50 patients with NIDDM, versus 0.88 { 0.01 mmol / L ( P nesium levels with age paralleled a gradual rise in blood pressure. 21 These early reports were supported õ .001 ) in a well matched control group. 39 Resnick et al found that both serum ionized magnesium by very recent studies showing a suppression of intracellular free magnesium with age, 22 suggesting a role ( 0.552 { 0.008 v 0.630 { 0.008 mmol / L, P õ .001 ) and intracellular free erythrocyte magnesium ( 184 { for magnesium deficit in the increased incidence of hypertension with age. Fasting levels of intracellular 14 v 223 { 8 mmol / L, P õ .001 ) , but not serum total magnesium were significantly reduced in NIDDM pafree magnesium are significantly lower in hypertensives as compared with normotensive subjects 23, 24 and tients, and a significant relationship was observed between serum and intracellular free magnesium ( r Å a strong inverse relationship is also present between the level of free magnesium and the height of blood 0.728, P ú .001 ) . 40 Low levels of plasma ionized magnesium were also confirmed by Meludu et al. 41 At the pressure, that is, the lower the free magnesium, the higher the blood pressure 24, 25 ( Figure 3 ) . Moreover, cellular level, subjects with type II diabetes mellitus, compared with nondiabetic subjects, displayed supin different experimental rat models of hypertension, alterations of the urinary excretion of magnesium may pressed cytosolic free magnesium levels and reciprocally increased cytosolic free calcium ( Ca i ) . 23 Intracelbe present, 26 and diets that raised or lowered intracellular free magnesium, consistently lowered and lular free magnesium levels were closely and inversely related to the level of the fasting blood raised, respectively, blood pressure. 27 Similarly, in humans, the ability of a high salt diet to elevate blood glucose. 23 Indeed, glucose appears to contribute to cellular ion homeostasis, independently of insulin. The pressure is strictly related to its ability to suppress intracellular free magnesium and elevate calcium. role of hyperglycemia in the intracellular magnesium Conversely, the ability of the calcium-channel blocker nifedipine to lower blood pressure was also related to the pretreatment magnesium levels: the higher the magnesium, the greater the hypotensive effect. 28 Although therapeutical use of magnesium is beneficial in preeclampsia and eclampsia 29 and in patients with malignant hypertension, 30 the response to magnesium of essential hypertensives is inconsistent and heterogeneous. 31, 32 Blood pressure in some patients may worsen; in others, however, magnesium supplementation may have a significant hypotensive effect. 32 Thus, even if a role for decreased magnesium levels in the pathophysiology of hypertension appears likely, a consistent, reproducible effect of magnesium supplementation on blood pressure has not been confirmed in hypertension, and further data are needed to consider magnesium as a nonpharmacological tool for treating hypertension.
MAGNESIUM AND DIABETES
Hypomagnesemia in diabetic patients is a widely recognized finding. 33 -35 Mather et al used atomic absorption spectrophotometry to measure plasma magnesium levels in 582 unselected diabetic outpatients and in 140 control subjects, and observed that mean plasma magnesium levels were significantly lower in the diabetic patients than in control subjects, whereas 25% of the patients had values below those found in all control subjects. 36 Furthermore they showed that, in diabetic subjects, plasma magnesium levels were inversely correlated with metabolic control and di-FIGURE 3. Relationship of basal systolic blood pressure ( SBP ) rectly correlated with plasma albumin levels. Other ( top ) and basal diastolic blood pressure ( BDP ) ( bottom ) to studies have confirmed the high prevalence of hypo-basal erythrocyte intracellular free magnesium levels ( Mg i ) in magnesemia in non -insulin-dependent diabetes mel-normal and hypertensive subjects ( from Resnick et al, 25 with permission ) .
litus. 37, 38 In a study reported by Schnack et al, plasma
/ 2e0f$$2136 02-03-97 16:57:25 eajha EL: AJH depletion of diabetes has been confirmed by in vitro bolic control resulted in reduced urinary magnesium losses: a 10% decrease in fructosamine levels was asstudies where glucose in a specific, concentration-, and time-dependent manner, at concentrations achieved sociated with a 14% decrease in urinary magnesium excretion ( P õ .005 ) . 39 In a recent study, it was also clinically, and independent of insulin-elevated intracellular free calcium, and reciprocally lowered intraeryth-reported that hyperinsulinemia per se may be a cause of magnesium depletion. 48 These data open new inrocyte free magnesium. 42 Barbagallo et al recently reported that hyperglycemia also increases intracellular sight into the pathophysiology of magnesium depletion in the absence of poor metabolic control. As such, free calcium content of cultured vascular smooth muscle cells, suggesting an ionic mechanism for the in-it can be hypothesized also that in hypertensive patients with insulin resistance, hyperinsulinemia itself creased vasoconstriction present in chronic diabetic states.
43 might contribute to magnesium depletion.
Whatever is the cause of poor plasma and intracelWhy diabetic patients have lower plasma and erythrocyte magnesium concentrations than healthy sub-lular magnesium content, a depletion of magnesium seems to be a cofactor for a further derangement of jects is still a debated question. Two hypotheses have been suggested: a ) a low magnesium intake; and b ) insulin resistance. The pathogenetic role of depletion of magnesium in non -insulin-dependent diabetes increased urinary losses. With regard to low magnesium intake, changes in dietary habits in the western mellitus ( NIDDM ) is supported by The Nurses Health
Study showing an increased magnesium intake to be world have resulted in daily magnesium intake close to, or even below, the recommended daily allowances. associated with a significant decline in the incidence of NIDDM. 49 Several in vitro and in vivo studies have Studies performed recently in Denmark and in the USA 44, 45 have indicated that the diet of both insulin-been also provided to support a role of intracellular magnesium in the regulation of insulin action. dependent and non -insulin-dependent diabetic patients was magnesium deficient. In the study by
In vitro, a dose -response curve correlating in NIDDM patients the amount of insulin to the erythroSchmidt and Heins, only 20% of a group of patients with NIDDM had a diet reaching the RDA for magne-cyte magnesium accumulation showed a shift to the right of the curve. In addition, it was possible to demsium, and similar findings were reported for IDDM patients. 45 As far as magnesium urinary losses is con-onstrate that erythrocytes in NIDDM patients did not achieve the same maximal effect as those in healthy cerned, increased urinary losses of magnesium have frequently been reported in diabetic patients. McNair subjects. As for glucose transport, this observation suggests that a postreceptor defect is responsible for et al 46 studied 215 insulin-treated diabetic outpatients aged 7 to 70 years. These authors reported the occur-the impaired insulin-mediated transport of magnesium in NIDDM patients. Noithoh et al provided evirence of a definite hypomagnesemia ( below 2 SD of the normal range ) and hypomagnesuria ( above 2 SD dence in mouse diaphragm muscle that an increase in Ca 2/ influx into cells and Mg 2/ efflux from cells was of the normal range ) in 38.6% and 55% of the patients, respectively. They also observed that, in the presence associated with the inhibition of insulin-stimulated glucose uptake. 50 A clearer explanation for such pheof hypomagnesemia, the magnesium plasma levels were inversely correlated with the urinary magne-nomena was given by Suarez et al, who have investigated in rats the effects of 4 days of a low magnesiumsium excretion rate and also with fasting blood glucose values. They concluded that the tubular reab-containing diet on glucose disposal and insulin action on skeletal muscle. 51 Magnesium depletion induced a sorption of magnesium was decreased when severe hyperglycemia was present. Similarly, Ponder et al 47 severe insulin resistance that was shown to be dependent, at least in part, upon a defective tyrosine kinase reported that the mean urinary magnesium -creatinine ratio was significantly elevated in 220 conven-activity of the insulin receptors. Furthermore, Balon et al reported that the high fructose diet-induced insulin tionally treated children with insulin-dependent diabetes, compared with 33 healthy nondiabetic siblings; resistance reported in rats was not due, as currently believed, to fructose itself, but rather to the low magin that study, increased losses of magnesium were present even when glycemic control was considered nesium content of such commercial diets. 52 On the other hand, the same group reported that magnesium to be good. These authors concluded that children with insulin-dependent diabetes could be at risk of supplementation delayed the development of diabetes in a rat model of non -insulin-dependent diabetes mineral deficiencies ( including magnesium) in the absence of intensive insulin management. Djurhuus et mellitus. 53 Finally, in sheep, a magnesium-deficient diet was associated with a significant impairment of al, recently reported that IDDM patients were compared with a group of control subjects matched for insulin-mediated glucose uptake. 54 In whites, low intracellular erythrocyte magnesium age and sex. 44 The renal excretion of magnesium was 39% higher in 49 of the IDDM patients ( P õ .001 ) content was inversely related to basal plasma insulin concentrations and body mass index, while directly than in the controls. Interestingly, improved meta-/ 2e0f$$2136 02-03-97 16:57:25 eajha EL: AJH correlated with the Canard's K value at the intrave-this association, the underlying mechanisms that initiate and sustain the elevation of the blood pressure, metnous glucose tolerance test and glucose infusion rate during a euglycemic hyperinsulinemic glucose abolic abnormalities remains undefined. The recent finding that essential hypertension in the absence of clamp. 55 In Pima Indians, known to have a severe degree of insulin resistance, a lower erythrocyte magne-obesity or diabetes is itself an insulin-resistant state 62 has brought some authors to attribute to insulin a possisium accumulation in response to intravenous insulin infusion was found, 56 thus supporting the concept ble pathogenetic role in mediating this clinical linkage. 63 that the pathophysiological relationship between insulin resistance and poor intracellular magnesium content is independent of the race studied. Whether a deficient intracellular magnesium content is secondary to or precedes insulin resistance is a question that deserves further investigation ( see below ) . More recently, Alzaid et al have reported that, in subjects with NIDDM, insulin resistance impairs the ability of insulin to stimulate magnesium as well as glucose uptake. 57 Another way to support the hypothesis that magnesium deficiency may negatively affect insulin action is to supplement magnesium at pharmacological doses and to verify its effect on insulin action. Sjorgen et al, who supplemented 16 patients with IDDM with magnesium hydroxide for 21 weeks, found a significant increase in muscle magnesium concentrations. 58 Insulin requirements decreased significantly, whereas blood glucose and HbA 1c levels remained unchanged, which suggests increased insulin sensitivity. The effect of magnesium supplementation ( 2 g / day of magnesium pidolate, equivalent to 7 mmol magnesium/ day, for 4 weeks ) on insulin sensitivity was also studied in aged obese 59 and nonobese 60 NIDDM patients. Treatment resulted in significant increase in plasma and erythrocyte magnesium concentrations, and in modest but significant improvement in insulin-mediated glucose uptake. Analysis of substrate oxidation demonstrates that the improvement in insulin sensitivity was due mainly to an increase in glucose oxidation, whereas nonoxidative glucose metabolism, lipid and protein oxidation, and endogenous glucose production remained unaffected. 60 Similarly, no significant differences in insulin metabolic clearance rates were found. 60 Finally, in NIDDM patients, the dose -response curve between the daily magnesium supplements and the glucose insulin rate ( GIR ) ( a proxy of insulin-mediated glucose uptake ) demonstrated a progressive increase in GIR, which parallels the change in plasma and erythrocyte magnesium concentration ( Figure 4 ) .
CAN A DEFICIENT INTRACELLULAR MAGNESIUM JUSTIFY THE ASSOCIATION FIGURE 4 . Changes in plasma and erythrocyte magnesium concentrations and in glucose infusion rate ( GIR ) in three differ-
BETWEEN DIABETES AND HYPERTENSION? ent groups of non -insulin-dependent diabetic patients when dif-
The clinical association of essential hypertension with ferent doses of daily magnesium supplements were given. *P õ metabolic abnormalities, such as hyperinsulinemia, in-.05; * *P õ .01; * * *P õ .001 v subjects without magnesium sulin resistance, altered glucose tolerance, or frank supplements. Open triangle, P õ .05; open circle Å P õ .01; NIDDM , has long been appreciated. 61 However, de-closed triangle, P õ .05 between 5.1 and 11.5 mmol / day of magnesium.
spite the clinical significance that has been attached to / 2e0f$$2136 02-03-97 16:57:25 eajha EL: AJH Hyperinsulinemia, however, at least acutely, rather than ''causing'' hypertension, is a vasodilatory hormone, inducing frank hypotension in absence of an adequate, compensatory rise in sympathetic activity. Moreover, in vitro, at the cellular level, insulin blunts agonist-induced calcium elevations in vascular smooth muscle cells, and blocks calcium current. 64 Thus, it is reasonable to suggest that peripheral insulin resistance in hypertension may signal a lack of effective insulin action.
A linkage of alterations of intracellular free magnesium to this clinical association also may be hypothesized. Intracellular free magnesium is not only involved in regulating cardiac and smooth muscle con- ter release from nerve terminals, both centrally and peripherally. 65 Moreover, as described above, depletion of magnesium has been demonstrated in patients the higher the free calcium. 67 Overall, the relation bewith diabetes, insulin resistance, and hypertension.
tween cellular ions and insulin is a complex one, with What might be the basis for this common linkage of evidence suggesting that low intracellular concentramagnesium to blood pressure, diabetes, and insulin tions of magnesium ( and / or elevated concentrations responsiveness? One explanation may be the imporof calcium) are associated with insulin resistance. The tance of magnesium itself in the regulation of both same increased intracellular calcium concentrations cardiac and smooth muscle contraction as well as gluthat may blunt insulin action 69 also, independently, cose utilization. Thus magnesium, within the physioin pancreatic beta cells, stimulates insulin secretion, logic concentration range, stimulates Na-K-ATPase, leading to both hyperinsulinemia and insulin resiscalcium-activated potassium channel, and competes tance concurrently. On the other hand, insulin itself with calcium for binding on calmodulin. Similarly, may increase both intracellular free calcium and magmagnesium is critical for tyrosine kinase activity and nesium. 6,70 Definitive experiments have not yet been for the rate-limiting enzymes of glycolysis. Decreased performed to distinguish the ''chicken'' from the availability of magnesium would thus be expected to ''egg,'' that is, the extent to which the ionic abnormalienhance calcium-mediated vasoconstriction and / or ties present in these conditions represent a primary to blunt cardiac and smooth muscle relaxation, and defect causing altered insulin secretion and / or celluto decrease cellular glucose utilization, contributing to lar insulin responsiveness, or rather being secondary peripheral insulin resistance as a postreceptor defect.
to insulin resistance of other etiologies. Support for Suppression of intracellular free magnesium concenthe primacy of ion alterations to altered insulin retrations is itself known to decrease cellular glucose sponse comes from data suggesting that glucose-indeutilization, and thus to promote peripheral insulin rependent ionic effects of insulin are blunted in cells sistance as a postreceptor defect, 66 that is, the lower from magnesium-depleted hypertensive individuthe basal Mg i , the greater the amount of insulin reals, 71,72 the lower the Mg i , or the higher the basal Ca i , quired to metabolize the same glucose load, indicating the less responsive is the cell to insulin stimulation. decreased insulin sensitivity.
53 Thus, magnesium dePaolisso reported a blunted insulin-induced shift of ficiency may negatively affect both blood pressure magnesium into erythrocytes of magnesium-depleted and glucose metabolism ( Figure 5 ) . Magnesium can NIDDM subjects. 30 Yajnik et al reported that, after a also mediate altered blood pressure and glucose tolerstandard glucose tolerance test, the disposal rate of ance by virtue of its interaction with other ions, in glucose in a group of diabetic subjects was directly particular, calcium. As such, cytosolic free calcium related to fasting plasma magnesium concentrations, concentrations are directly related to the level of blood also confirming the role of magnesium in insulin senpressure and to the hyperinsulinemic response to glusitivity. 73 Nadler recently showed that magnesium decose. 67, 68 The opposite relation of free calcium and free ficiency produces insulin resistance, as determined by magnesium concentrations to these hemodynamic intravenous glucose tolerance tests, and thromboxane and metabolic events is presumably because cytosolic synthesis. 74 Specifically, in skeletal muscle and fat tisfree calcium and magnesium were themselves inversely related, that is, the lower the free magnesium, sue, insulin resistance would be the expected outcome might equally well be explained on the basis of altered cellular ion metabolism ( Figure 5 ) . At this stage in the development of a cellular ion-13. Ji BH, Erne P, Kiosky W, Buhler FR, Bolli P: Magnebased approach, it seems reasonable to suggest a ) the sium-induced vasodilatation is comparable to that incritical importance of magnesium metabolism in regu- cluding diabetes mellitus type II.
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